What is the impact of altered hepatic drug enzyme activity on drug effects?

Generally, if the activity of liver enzymes increases, it may accelerate drug metabolism, leading to reduced drug effects or development of tolerance. Conversely, decreased liver enzyme activity can slow down the biotransformation of drugs. If medication is necessary, it is recommended to first consult a professional physician. Detailed analysis is as follows:

Liver enzymes, as the core component of the hepatic microsomal mixed-function enzyme system, may influence the transformation and metabolism of drugs. When liver enzyme activity changes, it directly affects the rate of drug biotransformation and metabolism, thereby influencing the pharmacological effects of drugs.

When liver enzyme activity is enhanced, the drug metabolism process is accelerated. This means that the drug remains in the body for a shorter time, resulting in weakened pharmacological effects, faster drug clearance, reduced efficacy, and possibly even the development of tolerance. In such cases, patients may need to increase their dosage or switch to alternative medications to maintain therapeutic effectiveness.

Conversely, when liver enzyme activity is reduced, the rate of drug biotransformation slows down, prolonging the drug's presence in the body, increasing plasma drug concentrations, and enhancing pharmacological effects. This may lead to an increased risk of adverse effects or even drug toxicity. Therefore, when using liver enzyme inhibitors such as chloramphenicol, careful adjustment of drug dosage is necessary to prevent drug accumulation and potential adverse reactions.

When administering medications, a patient’s liver function status and changes in liver enzyme activity should be fully considered to ensure both efficacy and safety of the treatment.